21.63
전일 마감가:
$21.28
열려 있는:
$21.31
하루 거래량:
328.31K
Relative Volume:
1.14
시가총액:
$595.16M
수익:
$320.35M
순이익/손실:
$-75.01M
주가수익비율:
-9.0302
EPS:
-2.3953
순현금흐름:
$-113.17M
1주 성능:
+8.97%
1개월 성능:
+16.54%
6개월 성능:
+44.68%
1년 성능:
-1.41%
Fulgent Genetics Inc Stock (FLGT) Company Profile
명칭
Fulgent Genetics Inc
전화
626-350-0537
주소
4399 SANTA ANITA AVE, EL MONTE
Compare FLGT vs TMO, DHR, NTRA, IQV, A
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
FLGT
Fulgent Genetics Inc
|
21.63 | 562.69M | 320.35M | -75.01M | -113.17M | -2.3953 |
|
TMO
Thermo Fisher Scientific Inc
|
648.43 | 225.48B | 45.20B | 6.87B | 6.75B | 18.19 |
|
DHR
Danaher Corp
|
208.36 | 140.70B | 24.78B | 3.68B | 5.29B | 5.1743 |
|
NTRA
Natera Inc
|
345.34 | 47.41B | 2.50B | -226.32M | 71.51M | -1.6412 |
|
IQV
Iqvia Holdings Inc
|
268.82 | 43.09B | 16.63B | 1.39B | 2.12B | 8.0674 |
|
A
Agilent Technologies Inc
|
153.69 | 41.42B | 7.23B | 1.41B | 1.09B | 4.979 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-05 | 업그레이드 | UBS | Neutral → Buy |
| 2023-12-07 | 개시 | UBS | Neutral |
| 2022-12-08 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-11-18 | 개시 | Raymond James | Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-02-04 | 재개 | Piper Sandler | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Underperform |
| 2021-01-08 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2020-11-24 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-08-20 | 개시 | Oppenheimer | Outperform |
| 2020-05-29 | 개시 | BTIG Research | Buy |
| 2019-11-05 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2018-03-01 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-11-07 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
모두보기
Fulgent Genetics Inc 주식(FLGT)의 최신 뉴스
How Fulgent Genetics Inc. (FLGT) Affects Rotational Strategy Timing - Stock Traders Daily
Bank of New York Mellon Corp Purchases New Position in Fulgent Genetics, Inc. $FLGT - MarketBeat
Public Employees Retirement System of Ohio Makes New Investment in Fulgent Genetics, Inc. $FLGT - MarketBeat
Hsieh Ming Surrenders 4,392 Shares of Fulgent Genetics at $19.59 Each - Kalkine Media
Fulgent Genetics CFO Kim Paul Surrenders 2,087 Shares at $19.59 Each - Kalkine Media
Fulgent Genetics president and COO Xie Jian sells $41,809 in stock By Investing.com - Investing.com South Africa
Fulgent Genetics president and COO Xie Jian sells $41,809 in stock - Investing.com Australia
FLGT Q2 2026 Earnings: Wider-Than-Expected Loss of -$0.58 Pressures SharesEarnings Revision Downgrade - vinanet.vn
Fulgent Genetics CSO Hanlin Gao sells $32,885 in stock By Investing.com - Investing.com South Africa
Fulgent Genetics CSO Hanlin Gao sells $32,885 in stock - Investing.com India
Fulgent Genetics (NASDAQ:FLGT) COO Sells 2,127 Shares - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Insider Sells $32,891.18 in Stock - MarketBeat
Fulgent Genetics (NASDAQ: FLGT) officer to sell 45,304 vested shares for taxes - Stock Titan
Fulgent Genetics (FLGT) officer plans stock sale to cover taxes - Stock Titan
BlackRock Inc. Makes New $46.92 Million Investment in Fulgent Genetics, Inc. $FLGT - marketbeat.com
Precision Trading with Fulgent Genetics Inc. (FLGT) Risk Zones - Stock Traders Daily
Connor Clark & Lunn Investment Management Ltd. Purchases New Position in Fulgent Genetics, Inc. $FLGT - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Upgraded at Wall Street Zen - MarketBeat
Fulgent Genetics CSO Gao Hanlin sells $18,691 in stock By Investing.com - Investing.com Nigeria
Fulgent Genetics CSO Gao Hanlin sells $18,691 in stock - Investing.com India
Jian Xie Sells 1,193 Shares of Fulgent Genetics (NASDAQ:FLGT) Stock - MarketBeat
Fulgent Genetics COO Xie Jian disposes of $23,747 in company stock - Investing.com
Fulgent Genetics (NASDAQ: FLGT) holder plans tax-driven share sale - Stock Titan
Fulgent (FLGT) Technicals: Slides 0.10% to $19.90 at the Close; the Near-Term Reference Band Stretches From $18.90 to $20.89 under the Current SnapshotPrice Action Signals - vinanet.vn
Renaissance Technologies LLC Decreases Stock Position in Fulgent Genetics, Inc. $FLGT - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Share Price Crosses Below Fifty Day Moving AverageHere's What Happened - MarketBeat
Fulgent Genetics details new protocols for variant reclassification and segregation testing recommendations - tradersunion.com
Fulgent Genetics (FLGT) Q2 2026 Earnings Call Transcript - AOL.com
Fulgent Genetics, Inc. $FLGT Shares Purchased by Quantinno Capital Management LP - MarketBeat
Discipline and Rules-Based Execution in FLGT Response - Stock Traders Daily
Fulgent Genetics, Inc. $FLGT Shares Sold by Dimensional Fund Advisors LP - MarketBeat
Wall Street Zen Downgrades Fulgent Genetics (NASDAQ:FLGT) to Strong Sell - MarketBeat
Fulgent Genetics, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:FLGT) 2026-08-07 - Seeking Alpha
Price to sales forward of Fulgent Genetics, Inc. – MUN:7F0 - TradingView
Fulgent Genetics, Inc. (FLGT) Stock Analysis: Navigating a Complicated Financial Landscape in Healthcare - DirectorsTalk Interviews
FLGT Q1 2026 Earnings: Wider-than-Expected Loss Despite Positive Stock MovementEarnings Miss Alert - vinanet.vn
Fulgent Genetics (FLGT) Stock Gets Fair Value Boost After Analysts Raised Targets - Yahoo Finance
Fulgent Deadline Alert - TMX Newsfile
FLGT Maintained by Piper Sandler -- Price Target Raised to $19.0 - GuruFocus
Piper Sandler Maintains Fulgent Genetics(FLGT.US) With Hold Rating, Cuts Target Price to $19 - Moomoo
Fulgent Genetics Inc (7F0) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
FLGT Q1 2026 Earnings: EPS Misses Estimates by 23.6%, Shares Tumble 18%Pre-Announcement Alert - vinanet.vn
FLGT Q1 2026 Earnings: EPS Misses Estimates by 23.6% as Shares Slide 18%Revenue Miss Report - vinanet.vn
Fulgent Genetics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Fulgent Genetics Inc (FLGT) (Q2 2026) Earnings Call Highlights: Strategic Progress Amid Revenue ... By GuruFocus - Investing.com Canada
Earnings call transcript: Fulgent Genetics cuts 2026 outlook after q2 miss - Investing.com Nigeria
FLGT Looks 16.7% Undervalued on GF Value™ Despite Revenue Miss - GuruFocus
Fulgent Genetics (FLGT) Releases Q2 2026 Earnings: Revenue Growth but EPS Miss - Quiver Quantitative
Tranche Update on Fulgent Genetics, Inc.'s Equity Buyback Plan announced on March 8, 2022. - marketscreener.com
Fulgent Genetics, Inc. Revises Earnings Guidance for the Year Ending December 31, 2026 - marketscreener.com
Fulgent Genetics cuts FY26 revenue guidance amid billing delays - scanx.trade
Fulgent Genetics Inc (FLGT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):